Biological Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027
The Global Biological Drugs Market to grow with a CAGR of 10% over the forecast period from 2021-2027.
Biologics are drugs that exist in the form of genetically engineered proteins derived from human genes. According to the U.S. FDA, biological products may consist of sugars, proteins or nucleic acids, or complex combinations of these substances, or they may consist of living organisms such as cells and tissues. Most biologics are complex mixtures that cannot be readily characterized or identified, are heat-sensitive and susceptible to microbial contamination. Biological products are derived from a variety of natural sources, such as animals, humans, or microorganisms. These products consist of vaccines, blood and blood components, allergies, somatic cells, gene therapy, tissue and recombinant therapeutic proteins. Processes such as advanced biotechnology and complex processes are used to manufacture biologics.
Market Segments
By Product
• Monoclonal Antibodies
• Vaccines
• Recombinant Hormones/Proteins
• Gene-Based Biologics
• Cellular Based Biologics
• Others
By Application
• Autoimmune Diseases
• Cancer
• Infectious Diseases
• Rare Diseases
• Others
Key Players
Merck & Co. Inc., AbbVie, Inc., AstraZeneca Plc., Amgen, Inc., Bristol-Myers Squibb Co., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., GlaxoSmithKline Plc., Novartis AG, Pfizer, Inc., and Novo Nordisk A/Sare.
Scope of the Report
The research study analyzes the global Biological Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Biological Drugs Market Report
1. What was the Biological Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Biological Drugs Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Biological Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation